nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.112	0.156	CbGbCtD
Propafenone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0782	0.108	CbGbCtD
Propafenone—CYP2C8—Progesterone—uterine cancer	0.0742	0.103	CbGbCtD
Propafenone—CYP1A2—Progesterone—uterine cancer	0.0575	0.0797	CbGbCtD
Propafenone—CYP2C9—Progesterone—uterine cancer	0.0518	0.0719	CbGbCtD
Propafenone—ABCB1—Progesterone—uterine cancer	0.0503	0.0697	CbGbCtD
Propafenone—CYP2D6—Progesterone—uterine cancer	0.0474	0.0657	CbGbCtD
Propafenone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0455	0.0631	CbGbCtD
Propafenone—ABCB1—Dactinomycin—uterine cancer	0.0399	0.0553	CbGbCtD
Propafenone—CYP2C8—Etoposide—uterine cancer	0.0332	0.0461	CbGbCtD
Propafenone—CYP3A4—Progesterone—uterine cancer	0.0301	0.0418	CbGbCtD
Propafenone—CYP1A2—Etoposide—uterine cancer	0.0257	0.0357	CbGbCtD
Propafenone—ABCB1—Etoposide—uterine cancer	0.0225	0.0312	CbGbCtD
Propafenone—ABCB1—Doxorubicin—uterine cancer	0.0153	0.0213	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—uterine cancer	0.0145	0.0201	CbGbCtD
Propafenone—CYP3A4—Etoposide—uterine cancer	0.0135	0.0187	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—uterine cancer	0.00919	0.0128	CbGbCtD
Propafenone—Benazepril—MTHFR—uterine cancer	0.00124	0.569	CrCbGaD
Propafenone—Carvedilol—VEGFA—uterine cancer	0.000937	0.431	CrCbGaD
Propafenone—Dehydration—Doxorubicin—uterine cancer	0.000192	0.000693	CcSEcCtD
Propafenone—Thrombocytopenia—Etoposide—uterine cancer	0.000192	0.000691	CcSEcCtD
Propafenone—Tachycardia—Etoposide—uterine cancer	0.000191	0.000689	CcSEcCtD
Propafenone—Eosinophilia—Epirubicin—uterine cancer	0.000191	0.000689	CcSEcCtD
Propafenone—Liver function test abnormal—Doxorubicin—uterine cancer	0.000191	0.000688	CcSEcCtD
Propafenone—Skin disorder—Etoposide—uterine cancer	0.00019	0.000686	CcSEcCtD
Propafenone—Dry skin—Doxorubicin—uterine cancer	0.000189	0.000683	CcSEcCtD
Propafenone—Hyperhidrosis—Etoposide—uterine cancer	0.000189	0.000682	CcSEcCtD
Propafenone—Pancreatitis—Epirubicin—uterine cancer	0.000189	0.000682	CcSEcCtD
Propafenone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000189	0.00068	CcSEcCtD
Propafenone—Hypokalaemia—Doxorubicin—uterine cancer	0.000188	0.000678	CcSEcCtD
Propafenone—Angina pectoris—Epirubicin—uterine cancer	0.000188	0.000678	CcSEcCtD
Propafenone—Breast disorder—Doxorubicin—uterine cancer	0.000187	0.000673	CcSEcCtD
Propafenone—Anorexia—Etoposide—uterine cancer	0.000186	0.000673	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000186	0.000671	CcSEcCtD
Propafenone—Diarrhoea—Dactinomycin—uterine cancer	0.000185	0.000667	CcSEcCtD
Propafenone—Hypotension—Etoposide—uterine cancer	0.000183	0.00066	CcSEcCtD
Propafenone—Gastritis—Doxorubicin—uterine cancer	0.000183	0.000659	CcSEcCtD
Propafenone—Muscular weakness—Doxorubicin—uterine cancer	0.000182	0.000657	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000182	0.000657	CcSEcCtD
Propafenone—Dysuria—Epirubicin—uterine cancer	0.00018	0.000651	CcSEcCtD
Propafenone—Abdominal distension—Doxorubicin—uterine cancer	0.00018	0.000648	CcSEcCtD
Propafenone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000179	0.000647	CcSEcCtD
Propafenone—Influenza—Doxorubicin—uterine cancer	0.000178	0.000644	CcSEcCtD
Propafenone—Dysphagia—Doxorubicin—uterine cancer	0.000178	0.000644	CcSEcCtD
Propafenone—Pollakiuria—Epirubicin—uterine cancer	0.000178	0.000643	CcSEcCtD
Propafenone—Eosinophilia—Doxorubicin—uterine cancer	0.000177	0.000637	CcSEcCtD
Propafenone—Paraesthesia—Etoposide—uterine cancer	0.000176	0.000634	CcSEcCtD
Propafenone—Weight increased—Epirubicin—uterine cancer	0.000176	0.000633	CcSEcCtD
Propafenone—Pancreatitis—Doxorubicin—uterine cancer	0.000175	0.000631	CcSEcCtD
Propafenone—Weight decreased—Epirubicin—uterine cancer	0.000174	0.00063	CcSEcCtD
Propafenone—Dyspnoea—Etoposide—uterine cancer	0.000174	0.000629	CcSEcCtD
Propafenone—Hyperglycaemia—Epirubicin—uterine cancer	0.000174	0.000628	CcSEcCtD
Propafenone—Somnolence—Etoposide—uterine cancer	0.000174	0.000628	CcSEcCtD
Propafenone—Angina pectoris—Doxorubicin—uterine cancer	0.000174	0.000627	CcSEcCtD
Propafenone—Drowsiness—Epirubicin—uterine cancer	0.000172	0.00062	CcSEcCtD
Propafenone—Infestation—Epirubicin—uterine cancer	0.000172	0.00062	CcSEcCtD
Propafenone—Infestation NOS—Epirubicin—uterine cancer	0.000172	0.00062	CcSEcCtD
Propafenone—Vomiting—Dactinomycin—uterine cancer	0.000172	0.00062	CcSEcCtD
Propafenone—Rash—Dactinomycin—uterine cancer	0.00017	0.000615	CcSEcCtD
Propafenone—Decreased appetite—Etoposide—uterine cancer	0.00017	0.000614	CcSEcCtD
Propafenone—Renal failure—Epirubicin—uterine cancer	0.000169	0.00061	CcSEcCtD
Propafenone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000169	0.000609	CcSEcCtD
Propafenone—Fatigue—Etoposide—uterine cancer	0.000169	0.000609	CcSEcCtD
Propafenone—Neuropathy peripheral—Epirubicin—uterine cancer	0.000169	0.000608	CcSEcCtD
Propafenone—Stomatitis—Epirubicin—uterine cancer	0.000168	0.000605	CcSEcCtD
Propafenone—Jaundice—Epirubicin—uterine cancer	0.000168	0.000605	CcSEcCtD
Propafenone—Constipation—Etoposide—uterine cancer	0.000167	0.000604	CcSEcCtD
Propafenone—Pain—Etoposide—uterine cancer	0.000167	0.000604	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—uterine cancer	0.000167	0.000602	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000166	0.000598	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—uterine cancer	0.000165	0.000595	CcSEcCtD
Propafenone—Haematuria—Epirubicin—uterine cancer	0.000164	0.000592	CcSEcCtD
Propafenone—Hepatobiliary disease—Epirubicin—uterine cancer	0.000163	0.000587	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—uterine cancer	0.000162	0.000586	CcSEcCtD
Propafenone—Epistaxis—Epirubicin—uterine cancer	0.000162	0.000585	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—uterine cancer	0.000161	0.000582	CcSEcCtD
Propafenone—Feeling abnormal—Etoposide—uterine cancer	0.000161	0.000582	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—uterine cancer	0.000161	0.000581	CcSEcCtD
Propafenone—Nausea—Dactinomycin—uterine cancer	0.000161	0.000579	CcSEcCtD
Propafenone—Agranulocytosis—Epirubicin—uterine cancer	0.00016	0.000579	CcSEcCtD
Propafenone—Gastrointestinal pain—Etoposide—uterine cancer	0.00016	0.000577	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—uterine cancer	0.000159	0.000574	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—uterine cancer	0.000159	0.000574	CcSEcCtD
Propafenone—Infestation—Doxorubicin—uterine cancer	0.000159	0.000574	CcSEcCtD
Propafenone—Bradycardia—Epirubicin—uterine cancer	0.000157	0.000567	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—uterine cancer	0.000156	0.000564	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000156	0.000563	CcSEcCtD
Propafenone—Urticaria—Etoposide—uterine cancer	0.000155	0.000561	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—uterine cancer	0.000155	0.00056	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—uterine cancer	0.000155	0.00056	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—uterine cancer	0.000155	0.00056	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—uterine cancer	0.000155	0.000558	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—uterine cancer	0.000155	0.000558	CcSEcCtD
Propafenone—Body temperature increased—Etoposide—uterine cancer	0.000155	0.000558	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—uterine cancer	0.000154	0.000557	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—uterine cancer	0.000154	0.000557	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—uterine cancer	0.000154	0.000554	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—uterine cancer	0.000152	0.00055	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—uterine cancer	0.000152	0.000547	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—uterine cancer	0.000152	0.000547	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—uterine cancer	0.000151	0.000546	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00015	0.000543	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—uterine cancer	0.00015	0.000541	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—uterine cancer	0.000149	0.000537	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—uterine cancer	0.000148	0.000536	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—uterine cancer	0.000145	0.000525	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—uterine cancer	0.000144	0.00052	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—uterine cancer	0.000144	0.00052	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—uterine cancer	0.000144	0.000519	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—uterine cancer	0.000144	0.000518	CcSEcCtD
Propafenone—Flushing—Epirubicin—uterine cancer	0.000143	0.000517	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—uterine cancer	0.000143	0.000517	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—uterine cancer	0.000143	0.000517	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—uterine cancer	0.000143	0.000515	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—uterine cancer	0.000143	0.000515	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—uterine cancer	0.000142	0.000513	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000141	0.000509	CcSEcCtD
Propafenone—Asthenia—Etoposide—uterine cancer	0.00014	0.000506	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—uterine cancer	0.00014	0.000506	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—uterine cancer	0.00014	0.000505	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—uterine cancer	0.00014	0.000505	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—uterine cancer	0.000139	0.000503	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—uterine cancer	0.000139	0.000502	CcSEcCtD
Propafenone—Pruritus—Etoposide—uterine cancer	0.000138	0.000499	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—uterine cancer	0.000138	0.000498	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—uterine cancer	0.000138	0.000497	CcSEcCtD
Propafenone—Alopecia—Epirubicin—uterine cancer	0.000136	0.000492	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—uterine cancer	0.000135	0.000488	CcSEcCtD
Propafenone—Erythema—Epirubicin—uterine cancer	0.000134	0.000485	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—uterine cancer	0.000134	0.000485	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—uterine cancer	0.000134	0.000483	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—uterine cancer	0.000133	0.000482	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—uterine cancer	0.000133	0.00048	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—uterine cancer	0.000133	0.000478	CcSEcCtD
Propafenone—Flushing—Doxorubicin—uterine cancer	0.000133	0.000478	CcSEcCtD
Propafenone—Flatulence—Epirubicin—uterine cancer	0.000132	0.000478	CcSEcCtD
Propafenone—Tension—Epirubicin—uterine cancer	0.000132	0.000476	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—uterine cancer	0.000132	0.000475	CcSEcCtD
Propafenone—Nervousness—Epirubicin—uterine cancer	0.000131	0.000471	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—uterine cancer	0.00013	0.000468	CcSEcCtD
Propafenone—Dizziness—Etoposide—uterine cancer	0.000129	0.000467	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—uterine cancer	0.000129	0.000466	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—uterine cancer	0.000129	0.000465	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000129	0.000464	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—uterine cancer	0.000128	0.00046	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—uterine cancer	0.000127	0.000457	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—uterine cancer	0.000126	0.000455	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—uterine cancer	0.000125	0.000451	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—uterine cancer	0.000125	0.00045	CcSEcCtD
Propafenone—Vomiting—Etoposide—uterine cancer	0.000124	0.000449	CcSEcCtD
Propafenone—Erythema—Doxorubicin—uterine cancer	0.000124	0.000449	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—uterine cancer	0.000124	0.000449	CcSEcCtD
Propafenone—Anaemia—Epirubicin—uterine cancer	0.000124	0.000448	CcSEcCtD
Propafenone—Rash—Etoposide—uterine cancer	0.000123	0.000445	CcSEcCtD
Propafenone—Dermatitis—Etoposide—uterine cancer	0.000123	0.000445	CcSEcCtD
Propafenone—Headache—Etoposide—uterine cancer	0.000123	0.000442	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—uterine cancer	0.000123	0.000442	CcSEcCtD
Propafenone—Tension—Doxorubicin—uterine cancer	0.000122	0.00044	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—uterine cancer	0.000122	0.000439	CcSEcCtD
Propafenone—Malaise—Epirubicin—uterine cancer	0.000121	0.000437	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—uterine cancer	0.000121	0.000436	CcSEcCtD
Propafenone—Vertigo—Epirubicin—uterine cancer	0.000121	0.000436	CcSEcCtD
Propafenone—Syncope—Epirubicin—uterine cancer	0.000121	0.000435	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—uterine cancer	0.00012	0.000434	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—uterine cancer	0.00012	0.000431	CcSEcCtD
Propafenone—Palpitations—Epirubicin—uterine cancer	0.000119	0.000428	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—uterine cancer	0.000118	0.000426	CcSEcCtD
Propafenone—Cough—Epirubicin—uterine cancer	0.000117	0.000423	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—uterine cancer	0.000117	0.000423	CcSEcCtD
Propafenone—Convulsion—Epirubicin—uterine cancer	0.000116	0.00042	CcSEcCtD
Propafenone—Nausea—Etoposide—uterine cancer	0.000116	0.000419	CcSEcCtD
Propafenone—Hypertension—Epirubicin—uterine cancer	0.000116	0.000419	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000115	0.000416	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—uterine cancer	0.000115	0.000415	CcSEcCtD
Propafenone—Chest pain—Epirubicin—uterine cancer	0.000114	0.000413	CcSEcCtD
Propafenone—Myalgia—Epirubicin—uterine cancer	0.000114	0.000413	CcSEcCtD
Propafenone—Anxiety—Epirubicin—uterine cancer	0.000114	0.000411	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000114	0.00041	CcSEcCtD
Propafenone—Discomfort—Epirubicin—uterine cancer	0.000113	0.000408	CcSEcCtD
Propafenone—Malaise—Doxorubicin—uterine cancer	0.000112	0.000405	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—uterine cancer	0.000112	0.000404	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—uterine cancer	0.000112	0.000403	CcSEcCtD
Propafenone—Syncope—Doxorubicin—uterine cancer	0.000112	0.000402	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—uterine cancer	0.000111	0.000402	CcSEcCtD
Propafenone—Confusional state—Epirubicin—uterine cancer	0.000111	0.000399	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—uterine cancer	0.00011	0.000396	CcSEcCtD
Propafenone—Oedema—Epirubicin—uterine cancer	0.00011	0.000396	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—uterine cancer	0.000109	0.000394	CcSEcCtD
Propafenone—Infection—Epirubicin—uterine cancer	0.000109	0.000393	CcSEcCtD
Propafenone—Cough—Doxorubicin—uterine cancer	0.000108	0.000391	CcSEcCtD
Propafenone—Shock—Epirubicin—uterine cancer	0.000108	0.000389	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—uterine cancer	0.000108	0.000389	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—uterine cancer	0.000108	0.000388	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—uterine cancer	0.000107	0.000387	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—uterine cancer	0.000107	0.000387	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—uterine cancer	0.000107	0.000386	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—uterine cancer	0.000107	0.000384	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—uterine cancer	0.000106	0.000383	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—uterine cancer	0.000106	0.000382	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—uterine cancer	0.000106	0.000382	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—uterine cancer	0.000105	0.000381	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000105	0.000379	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—uterine cancer	0.000105	0.000377	CcSEcCtD
Propafenone—Anorexia—Epirubicin—uterine cancer	0.000105	0.000377	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—uterine cancer	0.000104	0.000374	CcSEcCtD
Propafenone—Hypotension—Epirubicin—uterine cancer	0.000102	0.00037	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—uterine cancer	0.000102	0.000369	CcSEcCtD
Propafenone—Oedema—Doxorubicin—uterine cancer	0.000101	0.000366	CcSEcCtD
Propafenone—Infection—Doxorubicin—uterine cancer	0.000101	0.000364	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.99e-05	0.00036	CcSEcCtD
Propafenone—Shock—Doxorubicin—uterine cancer	9.98e-05	0.00036	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—uterine cancer	9.95e-05	0.000359	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—uterine cancer	9.94e-05	0.000358	CcSEcCtD
Propafenone—Insomnia—Epirubicin—uterine cancer	9.92e-05	0.000358	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—uterine cancer	9.9e-05	0.000357	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—uterine cancer	9.86e-05	0.000356	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—uterine cancer	9.85e-05	0.000355	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—uterine cancer	9.81e-05	0.000354	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—uterine cancer	9.78e-05	0.000353	CcSEcCtD
Propafenone—Somnolence—Epirubicin—uterine cancer	9.75e-05	0.000352	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—uterine cancer	9.67e-05	0.000349	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—uterine cancer	9.65e-05	0.000348	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—uterine cancer	9.53e-05	0.000344	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—uterine cancer	9.48e-05	0.000342	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—uterine cancer	9.47e-05	0.000342	CcSEcCtD
Propafenone—Fatigue—Epirubicin—uterine cancer	9.46e-05	0.000341	CcSEcCtD
Propafenone—Pain—Epirubicin—uterine cancer	9.38e-05	0.000338	CcSEcCtD
Propafenone—Constipation—Epirubicin—uterine cancer	9.38e-05	0.000338	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.25e-05	0.000334	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—uterine cancer	9.18e-05	0.000331	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—uterine cancer	9.11e-05	0.000329	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—uterine cancer	9.05e-05	0.000326	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—uterine cancer	9.04e-05	0.000326	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—uterine cancer	9.02e-05	0.000325	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—uterine cancer	8.97e-05	0.000324	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—uterine cancer	8.93e-05	0.000322	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—uterine cancer	8.82e-05	0.000318	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.76e-05	0.000316	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—uterine cancer	8.75e-05	0.000316	CcSEcCtD
Propafenone—Urticaria—Epirubicin—uterine cancer	8.71e-05	0.000314	CcSEcCtD
Propafenone—Pain—Doxorubicin—uterine cancer	8.68e-05	0.000313	CcSEcCtD
Propafenone—Constipation—Doxorubicin—uterine cancer	8.68e-05	0.000313	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—uterine cancer	8.67e-05	0.000313	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—uterine cancer	8.67e-05	0.000313	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—uterine cancer	8.36e-05	0.000302	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—uterine cancer	8.3e-05	0.000299	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—uterine cancer	8.08e-05	0.000292	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—uterine cancer	8.06e-05	0.000291	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—uterine cancer	8.02e-05	0.000289	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—uterine cancer	8.02e-05	0.000289	CcSEcCtD
Propafenone—Asthenia—Epirubicin—uterine cancer	7.87e-05	0.000284	CcSEcCtD
Propafenone—Pruritus—Epirubicin—uterine cancer	7.76e-05	0.00028	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—uterine cancer	7.5e-05	0.000271	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—uterine cancer	7.48e-05	0.00027	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—uterine cancer	7.28e-05	0.000263	CcSEcCtD
Propafenone—Dizziness—Epirubicin—uterine cancer	7.25e-05	0.000262	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—uterine cancer	7.18e-05	0.000259	CcSEcCtD
Propafenone—Vomiting—Epirubicin—uterine cancer	6.97e-05	0.000252	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—uterine cancer	6.94e-05	0.00025	CcSEcCtD
Propafenone—Rash—Epirubicin—uterine cancer	6.91e-05	0.000249	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—uterine cancer	6.91e-05	0.000249	CcSEcCtD
Propafenone—Headache—Epirubicin—uterine cancer	6.87e-05	0.000248	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—uterine cancer	6.71e-05	0.000242	CcSEcCtD
Propafenone—Nausea—Epirubicin—uterine cancer	6.51e-05	0.000235	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—uterine cancer	6.45e-05	0.000233	CcSEcCtD
Propafenone—Rash—Doxorubicin—uterine cancer	6.4e-05	0.000231	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—uterine cancer	6.39e-05	0.000231	CcSEcCtD
Propafenone—Headache—Doxorubicin—uterine cancer	6.36e-05	0.000229	CcSEcCtD
Propafenone—Nausea—Doxorubicin—uterine cancer	6.03e-05	0.000217	CcSEcCtD
